Extract Chronic thromboembolic pulmonary hypertension (CTEPH) is characterised by organised thrombi in the pulmonary arteries and secondary distal pulmonary vasculopathy [1, 2]. Multimodal treatment has improved prognosis [1, 2]; pulmonary endarterectomy (PEA) is recommended for surgically accessible CTEPH, whereas balloon pulmonary angioplasty (BPA) is indicated for distal disease or persistent/recurrent pulmonary hypertension (PH) after PEA [1–4]. Pharmacological therapy is also a key component of multimodal treatment [1, 2, 5–9].
No takes yet. Share an insight, caveat, or question.
Nakano et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: